arrow
W

Wen Wee

cleveland clinic cancer center
H指数:34
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 2 study of futibatinib in combination with pembrolizumab in patients with FGF19 expressing advanced hepatocellular carcinoma

II期研究: futibatinib联合pembrolizumab治疗FGF19表达型晚期肝细胞癌患者的疗效观察

2026-08-250
OAAI
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study

rucaparib和脂质体伊立替康/5-氟尿嘧啶在转移性消化道肿瘤中的优化给药方案:一项1期研究

Cancer
IF5.1
2025-11-220
PRE
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study

一线阿替利珠单抗/贝伐珠单抗或度伐利尤单抗/特瑞普利单抗在晚期肝细胞癌中的应用:一项真实世界、多中心回顾性研究

2025-11-010
PRE
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
2022-11-2231
OA
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
2022-09-0140
PRE
Understanding Suboptimal Response to Immune Checkpoint Inhibitors

了解对免疫检查点抑制剂的次优反应

2022-03-276
PRE
ASO Visual Abstract: Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
2021-11-220
PRE